Estrogen neuroprotection against the neurotoxic effects of ethanol withdrawal: Potential mechanisms

Experimental Biology and Medicine

Volumn 230, Issue 1, 2005, Pages 8-22

  Jung, M E ^a,b   Gatch, M B ^a   Simpkins, J W ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^b Dept of Pharmacol and Neuroscience ^*  (United States)

Author keywords

Estrogen; Ethanol withdrawl; Neuroprotection; Oxidative stress; Protein kinase C

Indexed keywords

ALCOHOL; CASPASE; CHLORDIAZEPOXIDE; DIAZEPAM; DNA FRAGMENT; ESTROGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN KINASE C; PROTEIN KINASE C EPSILON;

ALCOHOL WITHDRAWAL; ALCOHOLISM; APOPTOSIS; BEHAVIOR DISORDER; ENZYME ACTIVATION; HUMAN; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PROTEIN DNA BINDING; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SHORT SURVEY;

EID: 11144278296     PISSN: 15353702     EISSN: None     Source Type: Journal    
DOI: 10.1177/153537020523000102     Document Type: Short Survey

References (223)

1. Grant BF, Dawson DA. Alcohol and drug use, abuse, and dependence among welfare recipients. Am J Public Health 86:1450-1454, 1996.
2. Eckardt MJ, Martin PR. Clinical assessment of cognition in alcoholism. Alcohol Clin Exp Res 10:123-127, 1986.
3. Adinoff B, Bone GH, Linnoila M. Acute ethanol poisoning and the ethanol withdrawal syndrome. Med Toxicol Adverse Drug Exp 3:172-196, 1988.
4. Freund G. Induction of physical dependence on alcohol in rodents. Adv Exp Med Biol 56:311-325, 1975.
5. Gatch MB, Lal H. Effects of ethanol and ethanol withdrawal on nociception in rats. Alcohol Clin Exp Res 23:328-333, 1999.
6. Little HJ. The contribution of electrophysiology to knowledge of the acute and chronic effects of ethanol. Pharmacol Ther 84:333-353, 1999.
7. Harford TC, Parker DA, Grant BF, Dawson DA. Alcohol use and dependence among employed men and women in the United States in 1988. Alcohol Clin Exp Res 16:146-148, 1992.
8. Wojnar M, Wasilewski D, Matsumoto H, Cedro A. Differences in the course of alcohol withdrawal in women and men: a Polish sample. Alcohol Clin Exp Res 21:1351-1355, 1997.
9. Stein MD, Cyr MG. Women and substance abuse. Med Clin North Am 81:979-998, 1997.
10. Breitenfeld D, Lang B, Thaller V, Breitenfeld T, De Syo D, Jagetic N. Psycho-social characleristics of female alcoholics. Coll Antropol 22:613-638, 1998.
11. Dahlgren L. Alcoholism in women-hidden abuse. Nord Med 104:212-213, 1989.
12. Moller-Leimkuhler AM, Schwarz R, Burtscheidt W, Gaebel W. Alcohol dependence and gender-role orientation. Eur Psychiatry 17:1-8, 2002.
13. Helzer JE, Pryzbeck TR. The co-occurrence of alcoholism with other psychiatric disorders in the general population and its impact on treatment. J Stud Alcohol 49:219-224, 1988.
14. Gomberg ES. Suicide risk among women with alcohol problems. Am J Public Health 79:1363-1365, 1989.
15. Parks CA, Hesselbrock MN, Hesselbrock VM, Segal B. Gender and reported health problems in treated alcohol dependent Alaska natives. J Stud Alcohol 62:286-293, 2001.
16. Trovato GM, Catalano D, Sciacchitano G, Zuccala G, Iannetti E. Resistive index of renal artery and blood pressure in postmenopausal women. Maturitas 41:223-230, 2002.
17. Agarwal DP. Cardioprotective effects of light-moderate consumption of alcohol: a review of putative mechanisms. Alcohol Alcohol 37:409-415, 2002.
18. Fadda F, Rossetti ZL. Chronic ethanol consumption: from neuroadaptation to neurodegeneration. Prog Neurobiol 56:385-431, 1998.
19. Ligumsky M, Sestieri M, Okon E, Ginsburg I. Antioxidants inhibit ethanol-induced gastric injury in the rat: role of manganese, glycine, and carotene. Scand J Gastroenterol 30:854-860, 1995.
20. Rubin E, Rottenberg H. Ethanol-induced injury and adaptation in biological membranes. Fed Proc 41:2465-2471, 1982.
21. Uysal M, Kutalp G, Ozdemirler G, Aykac G. Ethanol-induced changes in lipid peroxidation and glutathione content in rat brain. Drug Alcohol Depend 23:227-230, 1989.
22. Nordmann R, Ribiere C, Rouach H. Ethanol-induced lipid peroxidation and oxidative stress in extrahepatic tissues. Alcohol Alcohol 25:231-237, 1990.
23. Montoliu C, Valles S, Renau-Piqueras J, Guerri C. Ethanol-induced oxygen radical formation and lipid peroxidation in rat brain: effect of chronic alcohol consumption. J Neurochem 63:1855-1862, 1994.
24. Bengoechea O, Gonzalo LM. Effects of alcoholization on the rat hippocampus. Neurosci Lett 123:112-114, 1991.
25. Beracochea D, Lescaudron L, Tako A, Verna A, Jaffard R. Build-up and release from proactive interference during chronic ethanol consumption in mice: a behavioral and neuroanatomical study. Behav Brain Res 25:63-74, 1987.
26. Cadete-Leite A, Tavares MA, Uylings HB, Paula-Barbosa M. Granule cell loss and dendritic regrowth in the hippocampal dentate gyrus of the rat after chronic alcohol consumption. Brain Res 473:1-14, 1988.
27. Lee K, Dunwiddie T, Deitrich R, Lynch G, Hoffer B. Chronic ethanol consumption and hippocampal neuron dendritic spines: a morphometric and physiological analysis. Exp Neurol 71:541-549, 1981.
28. Phillips SC, Cragg BG. Alcohol withdrawal causes a loss of cerebellar Purkinje cells in mice. J Stud Alcohol 45:475-480, 1984.
29. Majchrowicz E. Reversal in central nervous system function during ethanol withdrawal in humans and experimental animals. Fed Proc 40:2065-2072, 1981.
30. Mello NK, Mendelson JH. Drinking patterns during work-contingent and noncontingent alcohol acquisition. Psychosom Med 34:139-164, 1972.
31. Gatch MB, Lal H. Animals models of the anxiogenic effects of ethanol withdrawal. Drug Development Research 54:95-115, 2001.
32. Karhunen PJ, Erkinjuntti T, Laippala P. Moderate alcohol consumption and loss of cerebellar Purkinje cells. BMJ 308:1663-1667, 1994.
33. Phillips SC, Harper CG, Kril J. A quantitative histological study of the cerebellar vermis in alcoholic patients. Brain 110(Pt 2):301-314, 1987.
34. Walker DW, Hunter BE, Abraham WC. Neuroanatomical and functional deficits subsequent to chronic ethanol administration in animals. Alcohol Clin Exp Res 5:267-282, 1981.
35. Pierce DR, Serbus DC, Light KE. Intragastric intubation of alcohol during postnatal development of rats results in selective cell loss in the cerebellum. Alcohol Clin Exp Res 17:1275-1280, 1993.
36. Jung ME, Yang SH, Brun-Zinkernagel AM, Simpkins JW. Estradiol protects against cerebellar damage and motor deficit in ethanol-withdrawn rats. Alcohol 26:83-93, 2002.
37. Sullivan EV, Rosenbloom MJ, Pfefferbaum A. Pattern of motor and cognitive deficits in detoxified alcoholic men. Alcohol Clin Exp Res 24:611-621, 2000.
38. Zou JY, Martinez DB, Neafsey EJ, Collins MA. Binge ethanol-induced brain damage in rats: effect of inhibitors of nitric oxide synthase. Alcohol Clin Exp Res 20:1406-1411, 1996.
39. Lundqvist C, Ailing C, Knoth R, Volk B. Intermittent ethanol exposure of adult rats: hippocampal cell loss after one month of treatment. Alcohol Alcohol 30:737-748, 1995.
40. Veatch LM, Gonzalez LP. Repeated ethanol withdrawal produces site-dependent increases in EEG spiking. Alcohol Clin Exp Res 20:262-267, 1996.
41. Allen E, Doisy EA. Landmark article Sept 8, 192.3. An ovarian hormone. Preliminary report on its localization, extraction and partial purification, and action in test animals. By Edgar Allen and Edward A. Doisy. J Am Med Assoc 250:2681-2683, 1983.
42. Liu R, Yang SH, Perez E, Yi KD, Wu SS, Eberst K, Prokai L, Prokai-Tatrai K, Cai ZY, Covey DF, Day AL, Simpkins JW. Neuroprotective effects of a novel non-receptor-binding estrogen analogue: in vitro and in vivo analysis. Stroke 33:2485-2491, 2002.
43. Shi J, Bui JD, Yang SH, He Z, Lucas TH, Buckley DL, Blackband SJ, King MA, Day AL, Simpkins JW. Estrogens decrease reperfusion-associated cortical ischemic damage: an MRI analysis in a transient focal ischemia model. Stroke 32:987-992, 2001.
44. Yang L, Long C, Faingold CL. Audiogenic seizure susceptibility is induced by termination of continuous infusion of gamma-amino-butyric acid or an N-methyl-D-aspartic acid antagonist into the inferior colliculus. Exp Neurol 171:147-152, 2001.
45. Faingold CL, N'Gouemo P, Riaz A. Ethanol and neurotransmitter interactions-from molecular to integrative effects. Prog Neurobiol 55:509-535, 1998,
46. Green PS, Simpkins JW. Neuroprotective effects of estrogens: potential mechanisms of action. Int J Dev Neurosci 18:347-358, 2000.
47. Lee SJ, McEwen BS. Neurotrophic and neuroprotective actions of estrogens and their therapeutic implications. Annu Rev Pharmacol Toxicol 41:569-591, 2001.
48. Simpkins JW, Rajakumar G, Zhang YQ, Simpkins CE, Greenwald D, Yu CJ, Bodor N, Day AL. Estrogens may reduce mortality and ischemic damage caused by middle cerebral artery occlusion in the female rat. J Neurosurg 87:724-730, 1997.
49. Yang SH, He Z, Wu SS, He YJ, Cutright J, Millard WJ, Day AL, Simpkins JW. 17-beta estradiol can reduce secondary ischemic damage and mortality of subarachnoid hemorrhage. J Cereb Blood Flow Metab 21:174-181, 2001.
50. Schmidt R, Fazekas F, Reinhart B, Kapeller P, Fazekas G, Offenbacher H, Eber B, Schumacher M, Freidl W. Estrogen replacement therapy in older women: a neuropsychological and brain MRI study. J Am Geriatr Soc 44:1307-1313, 1996.
51. Simpkins JW, Green PS, Gridley JS, Monck EK. Neuroprotective effects of estrogens. In: Bellino FL, Ed. Biology of Menopause. New York: Springer-Verlag pp103-111, 2000.
52. Simpkins JW, Singh M, Bishop J. The potential role for estrogen replacement therapy in the treatment of the cognitive decline and neurodegeneration associated with Alzheimer's disease. Neurobiol Aging 15(Suppl 2):S195-S197, 1994.
53. Curtis Hewitt S, Couse JF, Korach KS. Estrogen receptor transcription and transactivation: estrogen receptor knockout mice: what their phenotypes reveal about mechanisms of estrogen action. Breast Cancer Res 2:345-352, 2000.
54. Hall JM, Couse JF, Korach KS. The multifaceted mechanisms of estradiol and estrogen receptor signaling. J Biol Chem 276:36869-36872, 2001.
55. Klinge CM. Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res 29:2905-2919, 2001.
56. Kia HK, Yen G, Krebs CJ, Pfaff DW. Colocalization of estrogen receptor alpha and NMDA-2D mRNAs in amygdaloid and hypothalamic nuclei of the mouse brain. Brain Res Mol Brain Res 104:47-54, 2002.
57. Orikasa C, McEwen BS, Hayashi H, Sakuma Y, Hayashi S. Estrogen receptor alpha, but not beta, is expressed in the interneurons of the hippocampus in prepubertal rats: an in situ hybridization study. Brain Res Dev Brain Res 120:245-254, 2000.
58. Shughrue PJ, Lane MV, Merchenthaler I. Comparative distribution of estrogen receptor-alpha and -beta mRNA in the rat central nervous system. J Comp Neurol 388:507-525, 1997.
59. Osterlund MK, Hurd YL. Acute 17 beta-estradiol treatment down-regulates serotonin 5HT1A receptor mRNA expression in the limbic system of female rats. Brain Res Mol Brain Res 55:169-172, 1998.
60. Behl C, Holsboer F. The female sex hormone oestrogen as a neuroprotectant. Trends Pharmacol Sci 20:441-444, 1999.
61. Green PS, Bishop J, Simpkins JW. 17 alpha-estradiol exerts neuroprotective effects on SK-N-SH cells. J Neurosci 17:511-515, 1997.
62. Sawada H, Ibi M, Kihara T, Urushitani M, Akaike A, Shimohama S. Estradiol protects mesencephalic dopaminergic neurons from oxidative stress-induced neuronal death. J Neurosci Res 54:707-719, 1998.
63. Moosmann B, Behl C. The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties. Proc Natl Acad Sci U S A 96:8867-8872, 1999.
64. Regan RF, Guo Y. Estrogens attenuate neuronal injury due to hemoglobin, chemical hypoxia, and excitatory amino acids in murine cortical cultures. Brain Res 764:133-140, 1997.
65. Weaver CE Jr, Park-Chung M, Gibbs TT, Farb DH. 17beta-estradiol protects against NMDA-induced excitotoxicity by direct inhibition of NMDA receptors. Brain Res 761:338-341, 1997.
66. Wong M, Thompson TL, Moss RL. Nongenomic actions of estrogen in the brain: physiological significance and cellular mechanisms. Crit Rev Neurobiol 10:189-203. 1996.
67. Tsai EM, Wang SC, Lee JN, Hung MC. Akt activation by estrogen in estrogen receptor-negative breast cancer cells. Cancer Res 61:8390-8392, 2001.
68. Wiseman H, Duffy R. New advances in the understanding of the role of steroids and steroid receptors in disease. Biochem Soc Trans 29:205-209, 2001.
69. Bishop J, Simpkins JW. Estradiol treatment increases viability of glioma and neuroblastoma cells in vitro. Mol Cell Neurosci 5:303-308, 1994.
70. Behl C, Skutella T, Lezoualc'h F, Post A, Widmann M, Newton CJ, Holsboer F. Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Mol Pharmacol 51:535-541, 1997.
71. Behl C, Widmann M, Trapp T, Holsboer F. 17-beta estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem Biophys Res Commun 216:473-482, 1995.
72. Green PS, Gridley KE, Simpkins JW. Nuclear estrogen receptor-independent neuroprotection by estratrienes: a novel interaction with glutathione. Neuroscience 84:7-10, 1998.
73. Dykens JA, Simpkins JW, Wang J, Gordon K. Polycyclic phenols, estrogens and neuroprotection: a proposed mitochondrial mechanism. Exp Gerontol 38:101-107, 2003.
74. Behl C, Moosmann B. Oxidative nerve cell death in Alzheimer's disease and stroke: antioxidants as neuroprotective compounds. Biol Chem 383:521-536, 2002.
75. Ueda S, Masutani H, Nakamura H, Tanaka T, Ueno M, Yodoi J. Redox control of cell death. Antioxid Redox Signal 4:405-414, 2002.
76. Splettstoesser WD, Schuff-Werner P. Oxidative stress in phagocytes-"the enemy within." Microsc Res Tech 57:441-455, 2002.
77. Butterlield DA, Castegna A, Drake J, Scapagnini G, Calabrese V. Vitamin E and neurodegenerative disorders associated with oxidative stress. Nutr Neurosci 5:229-239, 2002.
78. Heap L, Ward RJ, Abiaka C, Dexter D, Lawlor M, Pratt O, Thomson A, Shaw K, Peters TJ. The influence of brain acetaldehyde on oxidative status, dopamine metabolism and visual discrimination task. Biochem Pharmacol 50:263-270, 1995.
79. Nordmann R, Ribiere C, Rouach H. Implication of free radical mechanisms in ethanol-induced cellular injury. Free Radic Biol Med 12:219-240, 1992.
80. Rao AV, Balachandran B. Role of oxidative stress and antioxidants in neurodegenerative diseases. Nutr Neurosci 5:291-309, 2002.
81. McDonough KH. Antioxidant nutrients and alcohol. Toxicology 189:89-97, 2003.
82. Golovko AI, Golovko SI, Leontieva LV, Zefirov SY. The influence of ethanol on the functional status of GABA(A) receptors. Biochemistry (Mosc) 67:719-729, 2002.
83. Inoue H, Shimizu I, Lu G, Itonaga M, Cui X, Okamura Y, Shono M, Honda H, Inoue S, Muramatsu M, Ito S. Idoxifene and estradiol enhance antiapoptotic activity through estrogen receptor-beta in cultured rat hepatocytes. Dig Dis Sci 48:570-580, 2003.
84. Mantle D, Preedy VR. Free radicals as mediators of alcohol toxicity. Adverse Drug React Toxicol Rev 18:235-252, 1999.
85. Zima T, Fialova L, Mestek O, Janebova M, Crkovska J, Malbohan I, Stipek S, Mikulikova L, Popov P. Oxidative stress, metabolism of ethanol and alcohol-related diseases. J Biomed Sci 8:59-70, 2001.
86. Fernandez-Checa JC, Garcia-Ruiz C, Colell A, Morales A, Mari M, Miranda M, Ardite E. Oxidative stress: role of mitochondria and protection by glutathione. Biofactors 8:7-11, 1998.
87. Dicker E, Cederbaum AI. Increased NADH-dependent production of reactive oxygen intermediates by microsomes after chronic ethanol consumption: comparisons with NADPH. Arch Biochem Biophys 293:274-280, 1992.
88. Adachi J. Membrane disorder and free radical. Nippon Hoigaku Zasshi 54:356-360, 2000.
89. Loguercio C, Clot P, Albano E, Argenzio F, Grella A, De Girolamo V, Delle Cave M, Del Vecchio Bianco C, Nardi G. Free radicals and not acetaldehyde influence the circulating levels of glutathione after acute or chronic alcohol abuse: in vivo and in vitro studies. Ital J Gastroenterol Hepatol 29:168-173, 1997.
90. Kurose I, Higuchi H, Kato S, Miura S, Watanabe N, Kamegaya Y, Tomita K, Takaishi M, Horie Y, Fukuda M, Mizukami K, Ishii H. Oxidative stress on mitochondria and cell membrane of cultured rat hepatocytes and perfused liver exposed to ethanol. Gastroenterology 112:1331-1343, 1997.
91. Fernandez-Checa JC, Kaplowitz N, Garcia-Ruiz C, Colell A. Mitochondrial glutathione: importance and transport. Semin Liver Dis 18:389-401, 1998.
92. Mansouri A, Demeilliers C, Amsellem S, Pessayre D, Fromenty B. Acute ethanol administration oxidatively damages and depletes mitochondrial DNA in mouse liver, brain, heart, and skeletal muscles: protective effects of antioxidants. J Pharmacol Exp Ther 298:737-743, 2001.
93. Minana JB, Gomez-Cambronero L, Lloret A, Pallardo FV, Del Olmo J, Escudero A, Rodrigo JM, Pelliin A, Vina JR, Vina J, Sastre J. Mitochondrial oxidative stress and CD95 ligand: a dual mechanism for hepatocyte apoptosis in chronic alcoholism. Hepatology 35:1205-1214, 2002.
94. Orellana M, Valdes E, Fernandez J, Rodrigo R. Effects of chronic ethanol consumption on extramitochondrial fatty acid oxidation and ethanol metabolism by rat kidney. Gen Pharmacol 30:719-723, 1998.
95. Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 11:81-128, 1991.
96. Hernandez-Munoz R, Montiel-Ruiz C, Vazquez-Martinez O. Gastric mucosal cell proliferation in ethanol-induced chronic mucosal injury is related to oxidative stress and lipid peroxidation in rats. Lab Invest 80:1161-1169, 2000.
97. Kvietys PR, Twohig B, Danzell J, Specian RD. Ethanol-induced injury to the rat gastric mucosa: role of neutrophils and xanthine oxidase-derived radicals. Gastroenterology 98:909-920, 1990.
98. Szelenyi I, Brune K. Possible role of oxygen free radicals in ethanol-induced gastric mucosal damage in rats. Dig Dis Sci 33:865-871, 1988.
99. Terano A, Hiraishi H, Ota S, Shiga J, Sugimoto T. Role of superoxide and hydroxyl radicals in rat gastric mucosal injury induced by ethanol. Gastroenterol Jpn 24:488-493, 1989.
100. Gutteridge JM, Halliwell B. Iron toxicity and oxygen radicals. Baillieres Clin Haematol 2:195-256, 1989.
101. Speir E, Yu ZX, Takeda K, Ferrans VJ, Cannon RO III. Antioxidant effect of estrogen on cytomegalovirus-induced gene expression in coronary artery smooth muscle cells. Circulation 102:2990-2996, 2000.
102. Behl C. Oestrogen as a neuroprotective hormone. Natl Rev Neurosci 3:433-442, 2002.
103. Sagara Y. Induction of reactive oxygen species in neurons by haloperidol. J Neurochem 71:1002-1012, 1998.
104. Vallett M, Tabatabaie T, Briscoe RJ, Baird TJ, Beatty WW, Floyd RA, Gauvin DV. Free radical production during ethanol intoxication, dependence, and withdrawal. Alcohol Clin Exp Res 21:275-285, 1997.
105. Gunasekar PG, Kanthasamy AG, Borowitz JL, Isom GE. NMDA receptor activation produces concurrent generation of nitric oxide and reactive oxygen species: implication for cell death. J Neurochem 65:2016-2021, 1995.
106. Yang CS, Tsai PJ, Lin NN, Liu L, Kuo JS. Elevated extracellular glutamate levels increased the formation of hydroxyl radical in the striatum of anesthetized rat. Free Radic Biol Med 19:453-459, 1995.
107. Singer CA, Figueroa-Masot XA, Batchelor RH, Dorsa DM. The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons. J Neurosci 19:2455-2463, 1999.
108. Gilman SC, Bonner MJ, Pellmar TC. Effect of oxidative stress on excitatory amino acid release by cerebral cortical synaptosomes. Free Radic Biol Med 15:671-675, 1993.
109. Pellegrini-Giampietro DE, Cherici G, Alesiani M, Carla V, Moroni F. Excitatory amino acid release from rat hippocampal slices as a consequence of free-radical formation. J Neurochem 51:1960-1963, 1988.
110. Volterra A, Trotti D, Tromba C, Floridi S, Racagni G. Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes. J Neurosci 14:2924-2932, 1994.
111. Tsai GE, Ragan P, Chang R, Chen S, Linnoila VM, Coyle JT. Increased glutamatergic neurotransmission and oxidative stress after alcohol withdrawal. Am J Psychiatry 155:726-732, 1998.
112. Bleich S, Degner D, Sperling W, Bonsch D, Thurauf N, Kornhuber J. Homocysteine as a neurotoxin in chronic alcoholism. Prog Neuropsychopharmacol Biol Psychiatry 28:453-464, 2004.
113. Singer CA, Rogers KL, Dorsa DM. Modulation of Bcl-2 expression: a potential component of estrogen protection in NT2 neurons. Neuroreport 9:2565-2568, 1998.
114. Schwartz RD, Skolnick P, Paul SM. Regulation of gamma-amino-butyric acid/barbiturate receptor-gated chloride ion flux in brain vesicles by phospholipase A2: possible role of oxygen radicals. J Neurochem 50:565-571, 1988.
115. Braughler JM. Lipid peroxidation-induced inhibition of gamma-aminobutyric acid uptake in rat brain synaptosomes: protection by glucocorticoids. J Neurochem 44:1282-1288, 1985.
116. Sharma HS, Sjoquist PO. A new antioxidant compound H-290/51 modulates glutamate and GABA immunoreactivity in the rat spinal cord following trauma. Amino Acids 23:261-272, 2002.
117. Lyden PD, Jackson-Friedman C, Shin C, Hassid S. Synergistic combinatorial stroke therapy: a quantal bioassay of a GABA agonist and a glutamate antagonist. Exp Neurol 163:477-489, 2000.
118. Schwartz-Bloom RD, Sah R. Gamma-aminobutyric acid(A) neurotransmission and cerebral ischemia. J Neurochem 77:353-371, 2001.
119. Jung ME, Watson DG, Wen Y, Simpkins JW. Role of protein kinase C in estrogen protection against apoptotic cerebellar cell death in ethanol withdrawn rats. Alcohol 31:39-48, 2003.
120. Jung ME, Wallis CJ, Gatch MB, Lal H. Sex differences in the pentylenetetrazol-like stimulus induced by ethanol withdrawal. J Pharmacol Exp Ther 291:576-582, 1999.
121. Little HJ, Dolin SJ, Whittington MA. Calcium channel antagonists prevent adaptive responses to ethanol. Alcohol Alcohol Suppl 2:263-267, 1993.
122. Littleton JM, Little HJ, Whittington MA. Effects of dihydropyridine calcium channel antagonists in ethanol withdrawal: doses required, stereospecificity and actions of Bay K 8644. Psychopharmacology (Berl) 100:387-392, 1990.
123. Nagy J. Alcohol dependence at the cellular level: effects of ethanol on calcium homeostasis of IM-9 human lymphoblast cells. J Stud Alcohol 61:225-231, 2000.
124. Kouoh F, Gressier B, Dine T, Luyckx M, Brunei C, Ballester L, Cazin JC. Antioxidant effects and anti-elastase activity of the calcium antagonist nicardipine on activated human and rabbit neutrophils-a potential antiatherosclerotic property of calcium antagonists? Cardiovasc Drugs Ther 16:515-520, 2002.
125. Oyama Y, Chikahisa L, Matoba H, Furukawa K. Attenuation of Ca(2+)-induced increase in oxidative metabolism by cooling and calmodulin antagonist in mammalian brain neurons: a flow-cytometric study. Brain Res 664:220-224, 1994.
126. Sur P, Sribnick EA, Wingrave JM, Nowak MW, Ray SK, Banik NL. Estrogen attenuates oxidative stress-induced apoptosis in C6 glial cells. Brain Res 971:178-188, 2003.
127. Chen X, Moore-Nichols D, Nguyen H, Michaelis EK. Calcium influx through NMDA receptors, chronic receptor inhibition by ethanol and 2-amino-5- phosponopentanoic acid, and receptor protein expression. J Neurochem 72:1969-1980, 1999.
128. Hoffman PL, Rabe CS, Moses F, Tabakoff B. N-methyl-D-aspartate receptors and ethanol: inhibition of calcium flux and cyclic GMP production. J Neurochem 52:1937-1940, 1989.
129. Hoffman PL, Iorio KR, Snell LD, Tabakoff B. Attenuation of glutamate-induced neurotoxicity in chronically ethanol-exposed cerebellar granule cells by NMDA receptor antagonists and ganglioside GM1. Alcohol Clin Exp Res 19:721-726, 1995.
130. McMahon T, Andersen R, Metten P, Crabbe JC, Messing RO. Protein kinase C epsilon mediates up-regulation of N-type calcium channels by ethanol. Mol Pharmacol 57:53-58, 2000.
131. Messing RO, Sneade AB, Savidge B. Protein kinase C participates in up-regulation of dihydropyridine-sensitive calcium channels by ethanol. J Neurochem 55:1383-1389, 1990.
132. Gerstin EH Jr, McMahon T, Dadgar J, Messing RO. Protein kinase Cdelta mediates ethanol-induced up-regulation of L-type calcium channels. J Biol Chem 273:16409-16414, 1998.
133. Walter HJ, McMahon T, Dadgar J, Wang D, Messing RO. Ethanol regulates calcium channel subunits by protein kinase C delta-dependent and -independent mechanisms. J Biol Chem 275:25717-25722, 2000.
134. Shibata S, Shindou T, Tominaga K, Watanabe S. Calcium channel blockers improve hypoxia/hypoglycemia-induced impairment of rat hippocampal 2-deoxyglucose uptake in vitro after ethanol withdrawal. Brain Res 673:320-324, 1995.
135. Smaili SS, Hsu YT, Carvalho AC, Rosenstock TR, Sharpe JC, Youle RJ. Mitochondria, calcium and pro-apoptotic proteins as mediators in cell death signaling. Braz J Med Biol Res 36:183-190, 2003.
136. Gupta PD, Pushkala K. Importance of the role of calcium in programmed cell death: a review. Cytobios 99:83-95, 1999.
137. Hosoda T, Nakajima H, Honjo H. Estrogen protects neuronal cells from amyloid beta-induced apoptotic cell death. Neuroreport 12:1965-1970, 2001.
138. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239-257, 1972.
139. Olney JW, Wozniak DF, Jevtovic-Todorovic V, Ikonomidou C. Glutamate signaling and the fetal alcohol syndrome. Ment Retard Dev Disabil Res Rev 7:267-275, 2001.
140. Ikonomidou C, Bittigau P, Ishimaru MJ, Wozniak DF, Koch C, Genz K, Price MT, Stefovska V, Horster F, Tenkova T, Dikranian K, Olney JW. Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome. Science 287:1056-1060, 2000.
141. Slomiany BL, Piotrowski J, Slomiany A. Suppression of caspase-3 and nitric-oxide synthase-2 during buccal mucosal ulcer healing: effect of chronic alcohol ingestion. IUBMB Life 48:121-125, 1999.
142. Freund G. Apoptosis and gene expression: perspectives on alcohol-induced brain damage. Alcohol 11:385-387, 1994.
143. Singhal PC, Reddy K, Ding G, Kapasi A, Franki N, Ranjan R, Nwakoby IE, Gibbons N. Ethanol-induced macrophage apoptosis: the role of TGF-beta. J Immunol 162:3031-3036, 1999.
144. Spyridopoulos I, Wischhusen J, Rabenstein B, Mayer P, Axel DI, Frohlich KU, Karsch KR. Alcohol enhances oxysterol-induced apoptosis in human endothelial cells by a calcium-dependent mechanism. Arterioscler Thromb Vasc Biol 21:439-444, 2001.
145. Bautista AP. Chronic alcohol intoxication primes Kupffer cells and endothelial cells for enhanced CC-chemokine production and concomitantly suppresses phagocytosis and chemotaxis. Front Biosci 7:a117-a125, 2002.
146. Chen A, Zhang L, Xu J, Tang J. The antioxidant (-)-epigallocatechin-3- gallate inhibits activated hepatic stellate cell growth and suppresses acetaldehyde-induced gene expression. Biochem J 368:695-704, 2002.
147. Adachi M, Ishii H. Role of mitochondria in alcoholic liver injury. Free Radic Biol Med 32:487-491, 2002.
148. Higuchi H, Kurose I, Kato S, Miura S, Ishii H. Ethanol-induced apoptosis and oxidative stress in hepatocytes. Alcohol Clin Exp Res 20:340A-346A, 1996.
149. Pandey SC, Roy A, Mittal N. Effects of chronic ethanol intake and its withdrawal on the expression and phosphorylation of the creb gene transcription factor in rat cortex. J Pharmacol Exp Ther 296:857-868, 2001.
150. Choi KC, Kang SK, Tai CJ, Auersperg N, Leung PC. Estradiol upregulates antiapoptotic Bcl-2 messenger ribonucleic acid and protein in tumorigenic ovarian surface epithelium cells. Endocrinology 142:2351-2360, 2001.
151. Sudoh N, Toba K, Akishita M, Ako J, Hashimoto M, Iijima K, Kim S, Liang YQ, Ohike Y, Watanabe T, Yamazaki I, Yoshizumi M, Eto M, Ouchi Y. Estrogen prevents oxidative stress-induced endothelial cell apoptosis in rats. Circulation 103:724-729, 2001.
152. Basheer R RD, Porkka-Heiskanen T, Ramesh V, McCarley RW. Adenosine, prolonged wakefulness, and A1-activated NF-kappaB DNA binding in the basal forebrain of the rat. Neuroscience 104:731-739, 2001.
153. Bottex-Gauthier CPS, Favier A, Vidal DR. The Rel/NF-kappa-B transcription factors: complex role in cell regulation. Pathol Biol (Paris) 50:204-211, 2002.
154. Spek A, Reitsma P. Type-I protein-C deficiency caused by disruption of a hepatocyte nuclear factor (HNF)-6/HNF-1 binding site in the human protein-C gene promoter. Trends Cardiovasc Med 9:82-85, 1999.
155. Dekker LV, Parker PJ. Protein kinase C-a question of specificity. Trends Biochem Sci 19:73-77, 1994.
156. Hoffmann J. The potential for isozyme-selective modulation of protein kinase C. FASEB J 11:649-669, 1997.
157. Tanaka C, Nishizuka Y. The protein kinase C family for neuronal signaling. Annu Rev Neurosci 17:551-567, 1994.
158. Gressens P. VIP neuroprotection against excitotoxic lesions of the developing mouse brain. Ann N Y Acad Sci 897:109-124, 1999.
159. Inagaki K, Hahn HS, Dorn G II, Mochly-Rosen D. Additive protection of the ischemic heart ex vivo by combined treatment with delta-protein kinase C inhibitor and epsilon-protein kinase C activator. Circulation 108:869-875, 2003.
160. Maher P. How protein kinase C activation protects nerve cells from oxidative stress-induced cell death. J Neurosci 21:2929-2938, 2001.
161. Mochly-Rosen D, Kauvar LM. Modulating protein kinase C signal transduction. Adv Pharmacol 44:91-145, 1998.
162. Shinomura T, Asaoka Y, Oka M, Yoshida K, Nishizuka Y. Synergistic action of diacylglycerol and unsaturated fatty acid for protein kinase C activation: its possible implications. Proc Natl Acad Sci U S A 88:5149-5153, 1991.
163. Finco TS, Baldwin AS. Mechanistic aspects of NF-kappa B regulation: the emerging role of phosphorylation and proteolysis. Immunity 3:263-272, 1995.
164. Karin M, Smeal T. Control of transcription factors by signal transduction pathways: the beginning of the end. Trends Biochem Sci 17:418-422, 1992.
165. Siebenlist U, Brown K, Franzoso G. NF-κB: a mediator of pathogen and stress responses. In: Bauerele PA, Ed. Inducible Gene Expression. Boston: Birkhauser, pp135-147, 1995.
166. Blumberg PM. Complexities of the protein kinase C pathway. Mol Carcinog 4:339-344, 1991.
167. Stabel S, Parker PJ. Protein kinase C. Pharmacol Ther 51:71-95, 1991.
168. Cross TG, Scheel-Toellner D, Henriquez NV, Deacon E, Salmon M, Lord JM. Serine/threonine protein kinases and apoptosis. Exp Cell Res 256:34-41, 2000.
169. Soh JW, Lee EH, Prywes R, Weinstein IB. Novel roles of specific isoforms of protein kinase C in activation of the c-fos serum response element. Mol Cell Biol 19:1313-1324, 1999.
170. Chen N, Ma W, Huang C, Dong Z. Translocation of protein kinase Cepsilon and protein kinase Cdelta to membrane is required for ultraviolet B-induced activation of mitogen-activated protein kinases and apoptosis. J Biol Chem 274:15389-15394, 1999.
171. Knauf JA, Elisei R, Mochly-Rosen D, Liron T, Chen XN, Gonsky R, Korenberg JR, Fagin JA. Involvement of protein kinase Cepsilon (PKCepsilon) in thyroid cell death. A truncated chimeric PKCepsilon cloned from a thyroid cancer cell line protects thyroid cells from apoptosis. J Biol Chem 274:23414-23425, 1999.
172. Coe IR, Yao L, Diamond I, Gordon AS. The role of protein kinase C in cellular tolerance to ethanol. J Biol Chem 271:29468-29472, 1996.
173. Messing RO, Petersen PJ, Henrich CJ. Chronic ethanol exposure increases levels of protein kinase C delta and epsilon and protein kinase C-mediated phosphorylation in cultured neural cells. J Biol Chem 266:23428-23432, 1991.
174. Gordon AS, Yao L, Wu ZL, Coe IR, Diamond I. Ethanol alters the subcellular localization of delta- and epsilon protein kinase C in NG108-15 cells. Mol Pharmacol 52:554-559, 1997.
175. Olive MF, Mehmert KK, Nannini MA, Camarini R, Messing RO, Hodge CW. Reduced ethanol withdrawal severity and altered withdrawal-induced c-fos expression in various brain regions of mice lacking protein kinase C-epsilon. Neuroscience 103:171-179, 2001.
176. Olive MF, Mehmert KK, Messing RO, Hodge CW. Reduced operant ethanol self-administration and in vivo mesolimbic dopamine responses to ethanol in PKCepsilon-deficient mice. Eur J Neurosci 12:4131-4140, 2000.
177. Csukai M, Mochly-Rosen D. Pharmacologic modulation of protein kinase C isozymes: the role of RACKs and subcellular localisation. Pharmacol Res 39:253-259, 1999.
178. Mochly-Rosen D, Kauvar LM. Pharmacological regulation of network kinetics by protein kinase C localization. Semin Immunol 12:55-61, 2000.
179. Newton AC. Protein kinase C: structure, function, and regulation. J Biol Chem 270:28495-28498, 1995.
180. Lipton SA. Janus faces of NF-kappa B: neurodestruction versus neuroprotection. Nat Med 3:20-22, 1997.
181. Sun Z, Andersson R. NF-kappaB activation and inhibition: a review. Shock 18:99-106, 2002.
182. Zingarelli B, Sheehan M, Wong HR. Nuclear factor-kappaB as a therapeutic target in critical care medicine. Crit Care Med 31:S105-S111, 2003.
183. Fridmacher V, Kaltschmidt B, Goudeau B, Ndiaye D, Rossi FM, Pfeiffer J, Kaltschmidt C, Israel A, Memet S. Forebrain-specific neuronal inhibition of nuclear factor-kappaB activity leads to loss of neuroprotection. J Neurosci 23:9403-9408, 2003.
184. Nicholas RS, Compston A, Brown DR. Inhibition of tumour necrosis
185. Kaltschmidt C, Kaltschmidt B, Baeuerle PA. Brain synapses contain inducible forms of the transcription factor NF-kappa B. Mech Dev 43:135-147, 1993.
186. Ward RJ, Zhang Y, Crichton RR, Piret B, Piette J, de Witte P. Identification of the nuclear transcription factor NFkappaB in rat after in vivo ethanol administration. FEBS Lett 389:119-122, 1996.
187. Baeuerle PA, Baltimore D. NF-kappa B: Ten years after. Cell 87:13-20, 1996.
188. Chen XL, Tummala PE, Olliff L, Medford RM. E-selectin gene expression in vascular smooth muscle cells. Evidence for a tissue-specific represser protein. Circ Res 80:305-311, 1997.
189. Collins T, Read MA, Neish AS, Whitley MZ, Thanos D, Maniatis T. Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. FASEB J 9:899-909, 1995.
190. Remacle J, Raes M, Toussaint O, Renard P, Rao G. Low levels of reactive oxygen species as modulators of cell function. Mutat Res 316:103-122, 1995.
191. Vartiainen N, Goldsteins G, Keksa-Goldsteine V, Chan PH, Koistinaho J. Aspirin inhibits p44/42 mitogen-activated protein kinase and is protective against hypoxia/reoxygenation neuronal damage. Stroke 34:752-757, 2003.
192. Cassarino D, Halvorsen E, Swerdlow R, Abramova N, Parker WD J, Sturgill T, Bennett JJ. Interaction among mitochondria, mitogen-activated protein kinases, and nuclear factor-kappaB in cellular models of Parkinson's disease. J Neurochem 74:1384-1392, 2000.
193. Levites YYM, Maor G, Mandel S. Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclear factor-kappaB (NF-kappaB) activation and cell death by tea extracts in neuronal cultures. Biochem Pharmacol 63:21-29, 2002.
194. Meberg PJ, Kinney WR, Valcourt EG, Routtenberg A. Gene expression of the transcription factor NF-kappa B in hippocampus: regulation by synaptic activity. Brain Res Mol Brain Res 38:179-190, 1996.
195. O'Neill LA, Kaltschmidt C. NF-kappa B: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci 20:252-258, 1997.
196. Castagne V, Lefevre K, Clarke PG. Dual role of the NF-kappaB transcription factor in the death of immature neurons. Neuroscience 108:517-526, 2001.
197. Kukielka E, Dicker E, Cederbaum AI. Increased production of reactive oxygen species by rat liver mitochondria after chronic ethanol treatment. Arch Biochem Biophys 309:377-386, 1994.
198. Kono H, Rusyn I, Bradford BU, Connor HD, Mason RP, Thurman RG. Allopurinol prevents early alcohol-induced liver injury in rats. J Pharmacol Exp Ther 293:296-303, 2000.
199. Mandrekar P, Catalano D, Szabo G. Alcohol-induced regulation of nuclear regulatory factor-kappa beta in human monocytes. Alcohol Clin Exp Res 21:988-994, 1997.
200. Roman J, Colell A, Blasco C, Caballeria J, Pares A, Rodes J, Fernandez-Checa JC. Differential role of ethanol and acetaldehyde in the induction of oxidative stress in HEP G2 cells: effect on transcription factors AP-1 and NF-kappaB. Hepatology 30:1473-1480, 1999.
201. Zakhari S. NF-kappa B, a prototypical cytokine-regulated transcription factor: implications for alcohol-mediated responses. Alcohol Clin Exp Res 20:236A-242A, 1996.
202. Szabo G, Mandrekar P. Ethanol-mediated regulation of transcription factors in immunocompetent cells. Front Biosci 7:a80-a89, 2002.
203. Yao Z, Zhang J, Dai J, Keller ET. Ethanol activates NFkappaB DNA binding and p56lck protein tyrosine kinase in human osteoblast-like cells. Bone 28:167-173, 2001.
204. Kim WH, Hong F, Jaruga B, Hu Z, Fan S, Liang TJ, Gao B. Additive activation of hepatic NF-kappaB by ethanol and hepatitis B protein X (HBX) or HCV core protein: involvement of TNF-alpha receptor 1-independent and -dependent mechanisms. FASEB J 15:2551-2553, 2001.
205. Wheeler MD, Kono H, Rusyn I, Arteel GE, McCarty D, Samulski RJ, Thurman RG. Chronic ethanol increases adeno-associated viral transgene expression in rat liver via oxidant and NFkappaB-dependent mechanisms. Hepatology 32:1050-1059, 2000.
206. Stein B, Yang MX. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta. Mol Cell Biol 15:4971-4979, 1995.
207. McMurray RW, Ndebele K, Hardy KJ, Jenkins JK. 17-beta-estradiol suppresses IL-2 and IL-2 receptor. Cytokine 14:324-333, 2001.
208. Dodel RC, Du Y, Bales KR, Gao F, Paul SM. Sodium salicylate and 17beta-estradiol attenuate nuclear transcription factor NF-kappaB translocation in cultured rat astroglial cultures following exposure to amyloid A beta(1-40) and lipopolysaccharides. J Neurochem 73:1453-1460, 1999.
209. Harnish DC, Scicchitano MS, Adelman SJ, Lyttle CR, Karathanasis SK. The role of CBP in estrogen receptor cross-talk with nuclear factor-kappaB in HepG2 cells. Endocrinology 141:3403-3411, 2000.
210. Pelzer T, Neumann M, de Jager T, Jazbutyte V, Neyses L. Estrogen effects in the myocardium: inhibition of NF-kappaB DNA binding by estrogen receptor-alpha and -beta. Biochem Biophys Res Commun 286:1153-1157, 2001.
211. Wen Y, Onyewuchi O, Yang SH, Liu R, Simpkins JW. Increased beta-secretase activity and expression in rats following transient cerebral ischemia. Brain Res, 1009:1-8, 2004.
212. Evans MJ, Eckert A, Lai K, Adelman SJ, Harnish DC. Reciprocal antagonism between estrogen receptor and NF-kappaB activity in vivo. Circ Res 89:823-830, 2001.
213. Bodine PV, Harris HA, Komm BS. Suppression of ligand-dependent estrogen receptor activity by bone-resorbing cytokines in human osteoblasts. Endocrinology 140:2439-2451, 1999.
214. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science 281:1312-1316, 1998.
215. Robbins MA, Maksumova L, Pocock E, Chantler JK. Nuclear factor-kappaB translocation mediates double-stranded ribonucleic acid-induced NIT-1 beta-cell apoptosis and up-regulates caspase-12 and tumor necrosis factor receptor-associated ligand (TRAIL). Endocrinology 144:4616-4625, 2003.
216. Degen WG, Pruijn GJ, Raats JM, van Venrooij WJ. Caspase-dependent cleavage of nucleic acids. Cell Death Differ 7:616-627, 2000.
217. Krebs JF, Armstrong RC, Srinivasan A, Aja T, Wong AM, Aboy A, Sayers R, Pham B, Vu T, Hoang K, Karanewsky DS, Leist C, Schmitz A, Wu JC, Tomaselli KJ, Fritz LC. Activation of membrane-associated procaspase-3 is regulated by Bcl-2. J Cell Biol 144:915-926, 1999.
218. Yang X, Stennicke HR, Wang B, Green DR, Janicke RU, Srinivasan A, Seth P, Salvesen GS, Froelich CJ. Granzyme B mimics apical caspases: description of a unified pathway for trans-activation of executioner caspase-3 and -7. J Biol Chem 273:34278-34283, 1998.
219. Beckmann AM, Matsumoto I, Wilce PA. AP-1 and Egr DNA-binding activities are increased in rat brain during ethanol withdrawal. J Neurochem 69:306-314, 1997.
220. Dragunow M, Preston K. The role of inducible transcription factors in apoptotic nerve cell death. Brain Res Brain Res Rev 21:1-28, 1995.
221. Jover T, Tanaka H, Calderone A, Oguro K, Bennett MV, Etgen AM, Zukin RS. Estrogen protects against global ischemia-induced neuronal death and prevents activation of apoptotic signaling cascades in the hippocampal CA1. J Neurosci 22:2115-2124, 2002.
222. Rewal M, Jung ME, Wen Y, Brun-Zinkernagel AM, Simpkins JW. Role of the GABA-A system in behavioral, motoric and cerebellar protection by estrogen during ethanol withdrawal. Alcohol 31:49-61, 2003.
223. Watson D, Simpkins J. Estradiol exposure inhibits PKCε activation and ERK1/2 phosphorylation: potential mechanisms for its neuroprotective effects (abstract) Soc Neurosci p27. Abstract 655.9, 2001.